Live Breaking News & Updates on Health Asset Management

Stay updated with breaking news from Health asset management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tenaya Therapeutics (TNYA) Prices 8.89M Share Offering at $4.50/sh

Tenaya Therapeutics (TNYA) Prices 8.89M Share Offering at $4.50/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Leerink Partners , Health Sciences , Tenaya Therapeutics Inc , Health Asset Management , Syndicate Department , Column Group , Tenaya Therapeutics , Venrock Healthcare Capital Partners , Octagon Capital , Armistice Capital , Integral Health Asset Management , Soleus Capital , Sci Capital , Registration Statement ,

Ventyx Biosciences (NASDAQ:VTYX) Rating Lowered to Market Perform at Oppenheimer

Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) was downgraded by analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a report released on Tuesday, Briefing.com reports. A number of other equities research analysts have also recently commented on the stock. Stifel Nicolaus cut shares of Ventyx Biosciences from a “buy” rating […] ....

Ventyx Biosciences , Stifel Nicolaus , Peregrine Capital Management , Health Asset Management , Morgan Stanley , Ventyx Biosciences Inc , Wells Fargo Company , Virtu Financial , Credit Suisse Group , Securities Exchange Commission , Get Free Report , Suisse Group , Wells Fargo , Biosciences Stock Down , Director Somu Subramaniam , Exchange Commission , Capital Management , Ventyx Biosciences Daily , Nasdaq Vtyx , Oppenheimer Holdings Inc ,

Replimune Group (NASDAQ:REPL) Hits New 52-Week Low at $13.34

Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as $13.34 and last traded at $13.34, with a volume of 529686 shares traded. The stock had previously closed at $14.29. Analyst Ratings Changes Separately, HC Wainwright reduced their price objective on […] ....

Pamela Esposito , Replimune Group , Hedge Funds Weigh In On Replimune Group , Sectoral Asset Management Inc , News Ratings For Replimune Group Daily , Replimune Group Price Performance , Profund Advisors , Moody Aldrich Partners , Victory Capital Management Inc , Health Asset Management , Replimune Group Inc , Get Free Report , Capital Management , Asset Management , Aldrich Partners , Integral Health Asset Management , Replimune Group Daily , Nasdaq Repl ,